U.S. FDA approves full use of Pfizer vaccine

U.S. FDA approves full use of Pfizer vaccine


The U.S. Food and Drug Administration (FDA) has officially approved a new covidvirus infection vaccine jointly

developed by U.S. pharmaceutical company Pfizer and Germany’s Bioentech.

This is the first official approval of the covidvirus.

Until now, the Pfizer vaccine has been inoculated with emergency use approval. Approval for emergency use is only available in health crisis situations.

However, with the FDA’s formal approval of the vaccine, it can be used regardless of rejection.

“The Pfizer vaccine will be on the market as ‘Komirnati’ to prevent covidvirus aged 16 or older,”

the FDA said in a press release on the 23rd (local time). Comirnati is the name of the vaccine.토토사이트

“The vaccine can continue to be used under an emergency license, including administering a third dose to

individuals aged 12 to 15 and individuals with impaired immune systems,” he added.

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다